Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Short Interest Update

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) saw a significant drop in short interest in March. As of March 15th, there was short interest totalling 2,200 shares, a drop of 84.1% from the February 28th total of 13,800 shares. Based on an average trading volume of 29,700 shares, the short-interest ratio is currently 0.1 days.

Cardio Diagnostics Stock Performance

Shares of NASDAQ:CDIOW opened at $0.03 on Thursday. The company has a fifty day simple moving average of $0.06 and a 200 day simple moving average of $0.05. Cardio Diagnostics has a 12-month low of $0.02 and a 12-month high of $0.18.

Cardio Diagnostics Company Profile

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.